샘플 요청 목록

 카트 문의
시장보고서
상품코드
1985935

기관내 튜브 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 경로별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Endotracheal Tube Market Size, Share & Trends Analysis Report By Product, By Route, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 130 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,927,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 10,427,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 13,428,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

기관내 튜브 시장 요약

세계의 기관내 튜브 시장 규모는 2025년에 21억 5,000만 달러로 추정되며, 2033년까지 36억 달러에 달할 것으로 예측되며, 2026년부터 2033년까지 CAGR 6.80%로 성장할 것으로 전망됩니다.

이 시장은 주로 호흡기질환의 발생률 증가, 전신 마취가 필요한 수술 건수 증가, 집중 치료 서비스에 대한 수요 증가에 의해 주도되고 있습니다.

튜브의 소재 개선, 항균 코팅, 환자 안전성을 높이는 기능 향상 등의 기술적 진보도 시장 성장을 더욱 촉진하고 있습니다.

또한, 의료 인프라의 확충과 응급의료 서비스의 보급 확대도 전 세계 사용량 증가에 기여하고 있습니다. 만성폐쇄성폐질환(COPD) 세계 이니셔티브에 따르면, COPD의 전 세계 유병률은 10.3%에 달합니다. 세계보건기구(WHO)에 따르면 만성폐쇄성폐질환(COPD)과 천식은 가장 흔한 만성호흡기질환(CRD)이며, COPD는 CRD 관련 사망의 약 80%를 차지합니다. 전 세계 고령화와 여러 건강 문제로 인해 2050년까지 전 세계 COPD 환자 수는 23% 증가할 것으로 예상되며, 특히 여성과 중저소득 국가 주민들에게 불균형적으로 영향을 미칠 것으로 예상됩니다.

만성폐쇄성폐질환(COPD), 천식, 폐렴, 급성 호흡곤란 증후군(ARDS)을 포함한 호흡기질환의 유병률 증가는 시장의 주요 촉진요인으로 작용하고 있습니다. 중증 호흡기질환을 앓고 있는 환자가 증가함에 따라 중환자 치료, 응급 처치 및 수술 시 안정적인 기도 관리에 대한 수요가 증가하고 있습니다. 병원과 의료진은 효과적인 인공호흡을 보장하고 합병증을 예방하기 위해 기관내 튜브에 대한 의존도를 높이고 있으며, 이는 세계 시장 성장을 견인하고 있습니다.

자주 묻는 질문

  • 기관내 튜브 시장 규모는 어떻게 예측되나요?
  • 기관내 튜브 시장의 주요 성장 요인은 무엇인가요?
  • 기관내 튜브 시장의 기술적 진보는 어떤 영향을 미치고 있나요?
  • COPD의 전 세계 유병률은 어떻게 되나요?
  • 기관내 튜브에 대한 의존도가 증가하는 이유는 무엇인가요?

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 기관내 튜브 시장 : 변수, 동향, 범위

제4장 기관내 튜브 시장 : 제품별 추정·동향 분석

제5장 기관내 튜브 시장 : 경로별 추정·동향 분석

제6장 기관내 튜브 시장 : 용도별 추정·동향 분석

제7장 기관내 튜브 시장 : 최종 용도별 추정·동향 분석

제8장 기관내 튜브 시장 : 지역별 추정·동향 분석(제품별, 경로별, 용도별, 최종 용도별)

제9장 경쟁 구도

KSM 26.04.24

Endotracheal Tube Market Summary

The global endotracheal tube market size was estimated at USD 2.15 billion in 2025 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 6.80% from 2026 to 2033. The market is primarily driven by the rising incidence of respiratory diseases, the increasing number of surgical procedures requiring general anesthesia, and the growing demand for critical care services.

Technological advancements such as improved tube materials, antimicrobial coatings, and enhanced patient safety features further support market growth.

In addition, expanding healthcare infrastructure and greater adoption of emergency medical services contribute to increased usage worldwide. According to the Global Initiative of Chronic Obstructive Lung Disease, the global prevalence of COPD is 10.3%. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic respiratory diseases (CRDs), with COPD accounting for nearly 80% of CRD-related deaths. With an aging global population and multiple health challenges, COPD cases are projected to rise by 23% worldwide by 2050, disproportionately affecting women and individuals in low- and middle-income countries.

The rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and acute respiratory distress syndrome (ARDS), is a key driver of the market. As more patients experience severe respiratory conditions, the demand for reliable airway management during critical care, emergency interventions, and surgical procedures increases. Hospitals and healthcare providers are increasingly relying on endotracheal tubes to ensure effective ventilation and prevent complications, thereby fueling global market growth.

Global Endotracheal Tube Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endotracheal tube market report based on product, route, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Regular Endotracheal Tube
  • Reinforced Endotracheal Tube
  • Preformed Endotracheal Tube
  • Double lumen Endotracheal Tube
  • Route Outlook (Revenue, USD Million, 2021 - 2033)
  • Orotracheal
  • Nasotracheal
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Emergency Treatment
  • Therapy
  • Others
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Emergency Care Facilities/Urgent Care
  • Others (Long-Term Facilities, Physician Offices, Nursing Homes)
  • EMS (Fire/Rescue/Ambulance/Hospital Based EMS)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Route
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Endotracheal Tube Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of respiratory diseases
      • 3.2.1.2. Growth in surgical procedures globally
      • 3.2.1.3. Advancements in healthcare infrastructure
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced tubes
      • 3.2.2.2. Stringent regulatory approval processes
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expanding use in pediatric and specialized surgical care
      • 3.2.3.2. Technological innovation
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Risk of complications and safety concerns
  • 3.3. Endotracheal Tube Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Endotracheal Tube Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Endotracheal Tube Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Endotracheal Tube Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Regular Endotracheal Tube
    • 4.4.1. Regular endotracheal tube market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reinforced Endotracheal Tube
    • 4.5.1. Reinforced endotracheal tube market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Preformed Endotracheal Tube
    • 4.6.1. Preformed endotracheal tube market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Double lumen Endotracheal Tube
    • 4.7.1. Double lumen endotracheal tube market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Endotracheal Tube Market: Route Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Endotracheal Tube Market: Route Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Endotracheal Tube Market Size & Trend Analysis, by Route, 2021 to 2033 (USD Million)
  • 5.4. Orotracheal
    • 5.4.1. Orotracheal market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Nasotracheal
    • 5.5.1. Nasotracheal market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Endotracheal Tube Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Endotracheal Tube Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global Endotracheal Tube Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Emergency Treatment
    • 6.4.1. Emergency Treatment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Therapy
    • 6.5.1. Therapy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Endotracheal Tube Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Endotracheal Tube Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global Endotracheal Tube Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 7.4. Hospitals and Clinics
    • 7.4.1. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Emergency Care Facilities/Urgent Care
    • 7.6.1. Emergency care facilities/urgent care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. EMS (Fire/Rescue/Ambulance/Hospital Based EMS)
    • 7.7.1. EMS (fire/rescue/ambulance/hospital based EMS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others (Long-Term Facilities, Physician Offices, Nursing Homes)
    • 7.8.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Endotracheal Tube Market: Regional Estimates & Trend Analysis by Product, Route, Application and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Denmark endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Regulatory framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. China endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Japan endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait endotracheal tube market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
    • 9.5.6. Company Profiles
    • 9.5.7. Angiplast Pvt Ltd
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Advin Health Care
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Sterimed Group
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. ICU Medical, Inc.
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Medtronic (Covidien)
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Van Oostveen Medical B.V.
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Ambu A/S
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Intersurgical
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Vygon
      • 9.5.15.1. Company overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. Bactiguard AB
      • 9.5.16.1. Company overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product Benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Tuoren Medical
      • 9.5.17.1. Company overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product Benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Teleflex Incorporated
      • 9.5.18.1. Company overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product Benchmarking
      • 9.5.18.4. Strategic initiatives
    • 9.5.19. Convatec Inc.
      • 9.5.19.1. Company overview
      • 9.5.19.2. Financial performance
      • 9.5.19.3. Product Benchmarking
      • 9.5.19.4. Strategic initiatives
    • 9.5.20. Fuji Systems Corp
      • 9.5.20.1. Company overview
      • 9.5.20.2. Financial performance
      • 9.5.20.3. Product Benchmarking
      • 9.5.20.4. Strategic initiatives
    • 9.5.21. SEWOON MEDICAL Co., Ltd.
      • 9.5.21.1. Company overview
      • 9.5.21.2. Financial performance
      • 9.5.21.3. Product Benchmarking
      • 9.5.21.4. Strategic initiatives
    • 9.5.22. Mercury Medical
      • 9.5.22.1. Company overview
      • 9.5.22.2. Financial performance
      • 9.5.22.3. Product Benchmarking
      • 9.5.22.4. Strategic initiatives
    • 9.5.23. Well Lead Medical Co., Ltd
      • 9.5.23.1. Company overview
      • 9.5.23.2. Financial performance
      • 9.5.23.3. Product Benchmarking
      • 9.5.23.4. Strategic initiatives
    • 9.5.24. Viggo Medical Device
      • 9.5.24.1. Company overview
      • 9.5.24.2. Financial performance
      • 9.5.24.3. Product Benchmarking
      • 9.5.24.4. Strategic initiatives
    • 9.5.25. Medline
      • 9.5.25.1. Company overview
      • 9.5.25.2. Financial performance
      • 9.5.25.3. Product Benchmarking
      • 9.5.25.4. Strategic initiatives
    • 9.5.26. BESDATA
      • 9.5.26.1. Company overview
      • 9.5.26.2. Financial performance
      • 9.5.26.3. Product Benchmarking
      • 9.5.26.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제